Printer Friendly
The Free Library
19,111,409 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Pressure BioSciences, Inc. Announces Full Payment of Loan Receivable by CEO/Director.


WEST BRIDGEWATER, Mass. -- Pressure BioSciences, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: PBIO PBIO Processor Backplane I/O (NASA)
PBIO Portable Binary Input Output
) today announced that Richard T. Schumacher, President, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , and a Director of the Company, has delivered 249,875 shares of his PBIO common stock in full payment of his loan receivable to the Company, including all outstanding principal ($1,000,000) and interest accrued during Q4 2006 ($25,487). The number of shares was determined based upon a value of $4.104 per share, the volume weighted average trading price of the Company's common stock on the NASDAQ Capital Market Originally called the NASDAQ Small Cap Market, NASDAQ announced a name change to the NASDAQ Capital Market on September 27, 2005. [1]

The NASDAQ Capital Market exists for securities of smaller, less-capitalized companies (small caps) that do not qualify for
 during the 60 trading days ending on December 29, 2006.

As a result of this payment, the total number of the Company's issued and outstanding shares of common stock will decrease from 2,315,300 to 2,065,425, a decrease of 10.8%, and Mr. Schumacher will own 229,782 shares of PBIO common stock, or approximately 11.1% of the Company's issued and outstanding shares.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI PBI protein-bound iodine.

PBI
abbr.
protein-bound iodine


PBI,
n See iodine, protein-bound.


PBI

protein-bound iodine.
) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT (Private Communications Technology) A protocol from Microsoft that provides secure transactions over the Web. See security protocol. ). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Visit us at our website http://www.pressurebiosciences.com
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 29, 2006
Words:252
Previous Article:Xtreme Technologies Inc. Announces Pending Acquisition.
Next Article:Mission Oaks Declares First Dividend.



Related Articles
Pressure BioSciences, Inc. Provides Corporate Update.
Pressure BioSciences, Inc. to Present at the RedChip Small-Cap Investor Conference.
Pressure BioSciences, Inc. to Present at The Wall Street Analyst Forum's 17th Annual Analyst Conference.
Pressure BioSciences, Inc. to Present at the Edgewater Research Partners LLC Fall 2006 Micro/Small Cap Conference.
Pressure BioSciences, Inc. to Present at the ValueRich Small Cap Financial Conference and Expo.
Pressure BioSciences, Inc. Reports Third Quarter Financial Results.
Pressure BioSciences, Inc. Upgraded by EdgeWater Research Partners LLC.
Pressure BioSciences, Inc. to Present at the Friedland Investment Events' Life Sciences Conference.
Pressure BioSciences, Inc. to Present at the RedChip Phoenix Small-Cap Investor Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles